Disease Type: Cholangiocarcinoma
A Phase 1/2 Substudy of the MK-9999-U02 Master Protocol to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
Alleghany , Blacksburg , Roanoke , Salem , Wytheville